Search results for #AANAM
Still can’t get over how much fun I had presenting at #AANAM in Denver! @AANmember
"Ravulizumab was associated with a more than 90% reduction in experiencing first relapse relative to satralizumab & inebilizumab. Time to first relapse was comparable between ravulizumab & eculizumab." #NMOSD #ICYMI #AANAM @StaceyLClardy
"Ravulizumab was associated with a more than 90% reduction in experiencing first relapse relative to satralizumab & inebilizumab. Time to first relapse was comparable between ravulizumab & eculizumab." #NMOSD #ICYMI #AANAM @StaceyLClardy
How can we continue to address racial and ethnic disparities in Alzheimer research? Reña A. S. Robinson of @VanderbiltChem sat down at #AANAM to discuss more on this topic: neurologylive.com/view/insights-…
As part of a new #AANAM News Network, Dan Kremens discussed the common use of antiemetics in Parkinson disease, the real-world data surrounding these agents, and whether there are certain clinical advantages to apomorphine hydrochloride injection. 🔗neurologylive.com/view/using-ant…
#DNTH103 improves neurotransmission in a preclinical model of myasthenia gravis, according to results presented at the 2024 @AANmember Annual Meeting. Read more: brnw.ch/21wJklQ #RareDisease #AANAM #Neurology @dianthustx
The @AANmember Annual Meeting spotlighted the need for a more inclusive, advanced, holistic approach to #neurology in pioneering better #BrainHealthForAll. Get an in-depth look at our team’s #AANAM takeaways here: hubs.li/Q02vynCM0. #neuroscience #neuro #neuroTwitter
We recently spoke with @fredschaper_, of @BWHNeurology, at #AANAM about whether lesions causing #takotsubo cardiomyopathy map to a common #brain network. #Neurology Check out the conversation here: neurologylive.com/view/takotsubo…
We recently spoke with @fredschaper_, of @BWHNeurology, at #AANAM about whether lesions causing #takotsubo cardiomyopathy map to a common #brain network. #Neurology Check out the conversation here: neurologylive.com/view/takotsubo…
At this year's #AANAM, Jessica Ailani sat down to discuss eptinezumab as a preventive treatment for migraine 🧠 Listen in to why patients may receive benefit from either a 100 mg or 300 mg dose: neurologylive.com/view/consisten…
Learn about how low levels of #sleep can lead to #dementia in this #AANAM #congress wrap-up, featuring insights from @MaiNedergaard, Dr. Chia-Chun Chiang and Dr. Tomoko Kitago. Subscribe to our #neurology #newsletter to receive our full congress review: hubs.la/Q02vljVD0
Learn about how low levels of #sleep can lead to #dementia in this #AANAM #congress wrap-up, featuring insights from @MaiNedergaard, Dr. Chia-Chun Chiang and Dr. Tomoko Kitago. Subscribe to our #neurology #newsletter to receive our full congress review: hubs.la/Q02vljRM0
Takotsubo cardiomyopathy, frequently known as broken-heart syndrome, is triggered by emotional or physical distress. It's a surge of the sympathetic nervous system & can lead to sudden death. fredschaper_ explores its ties to the brain at the recent @AANmember conference. #AANAM
Takotsubo cardiomyopathy, frequently known as broken-heart syndrome, is triggered by emotional or physical distress. It's a surge of the sympathetic nervous system & can lead to sudden death. @fredschaper_ explores its ties to the brain at the recent @AANmember conference. #AANAM
@TanishaHillJ, of @UCSF, provided comment on her presentation from #AANAM examining the association of area deprivation index with cognitive functioning in Black women. 🎥 neurologylive.com/view/understan…
@DrTarunSinghal, of @BrighamWomens, discussed findings from a study investigating nasal foralumab in patients with non-active secondary progressive #MS. @TizianaLS #AANAM @AANmember 🎥 neurologylive.com/view/potential…
📣 @AANmember Summer Meeting Abstracts are due May 1st ⏱️ 🧠🔥 Submit yours now - Want to come but pressed for time? Remember, updates to previously presented research and encores from #AANAM are considered! See you in Atlanta! submissions.mirasmart.com/AANSummer2024/…
Daniel E. Kremens, MD, JD, of @TJUHospital, discussed the common use of antiemetics in #ParkinsonDisease, the real-world data surrounding these agents, and whether there are certain clinical advantages to apomorphine hydrochloride injection. #AANAM 📺 neurologylive.com/view/using-ant…
The ongoing X-TOLE open-label extension study is investigating the safety and efficacy of XEN1101 in focal #Epilepsy. In a recent interview, @frenchja of @nyulangone shares the interim findings: 👉 ow.ly/kfiN50Rn3n6 #CTSM #TrialUpdate #AANAM #Neurology #NeuroTwitter
Data suggest that certain patients may respond to mesenchymal stem cell therapy while others derive no benefit from the treatment. bit.ly/4d1StKK #ALSDisease #ALSTreatment #ALSResearch #StemCellTherapy #AANAM
30th National Neurology conference at Peshawar on 27th April 24 chairman of session #AANAM